Loading...

QGN

QGN

QIAGEN NV

(QGEN)

2025 6-K

Quarterly Report Update

7 May '26

Financial Results Report

7 May '26

Financial Results Announcement

5 Feb '26

Share Repurchase Plan

19 Dec '25

Quarterly Report

5 Nov '25

Quarterly Updates

5 Nov '25

Convertible Bonds Offering

29 Aug '25

Quarterly Report

21 Aug '25

Financial Results Adjusted

6 Aug '25

Management Update

27 Jun '25

Quarterly Report

12 May '25

Financial Results Release

8 May '25

Q1 2025 Results

8 Apr '25

Financial Results Report

6 Feb '25

Share Repurchase Plan

16 Jan '25

Shareholder Return Plan

13 Jan '25

Quarterly Report

7 Nov '24

Quarterly Results

7 Nov '24

Accountant Change

7 Nov '24

Convertible Bonds Offering

4 Sep '24

Convertible Bond Offering

3 Sep '24

Quarterly Report Filed

1 Aug '24

Financial Results Update

1 Aug '24

Annual Meeting Notice

1 Aug '24

Capital Markets Day

21 Jun '24

Product Discontinuation

6 Jun '24

Quarterly Report

30 Apr '24

Quarterly Results Report

30 Apr '24

Financial Results Announcement

8 Feb '24

Share Repurchase Plan

22 Jan '24

Shareholder Return Plan

8 Jan '24

External Links:

SEC

On November 4, 2025, QIAGEN N.V. reported its third-quarter results, announced plans to acquire Parse Biosciences, and revealed a plan to return up to $500 million to shareholders through a synthetic share repurchase. Additionally, CEO Thierry Bernard will step down.

AI Assistant

QIAGEN NV

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.